Requirement of the NF-κB pathway for induction of Wnt-5A by interleukin-1β in condylar chondrocytes of the temporomandibular joint: Functional crosstalk between the Wnt-5A and NF-κB signaling pathways

Osteoarthritis and Cartilage

Volumn 19, Issue 1, 2011, Pages 111-117

  Ge, Xian Peng ^a   Gan, Ye Hua ^a   Zhang, Chen Guang ^b   Zhou, Chun Yan ^b   Ma, Kang Tao ^b   Meng, Juan Hong ^a   Ma, Xu Chen ^a  

^a PEKING UNIVERSITY   (China)

^b PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

Author keywords

Chondrocyte; Interleukin 1 ; NF B; Temporomandibular joint; Wnt 5A

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; INTERSTITIAL COLLAGENASE; RNA; WNT5A PROTEIN;

ANIMAL CELL; ARTICLE; CANCER CELL; CARTILAGE CELL; CHONDROSARCOMA; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE OVEREXPRESSION; IMMUNE SYSTEM; MANDIBLE CONDYLE; NONHUMAN; OSTEOARTHRITIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RABBIT; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TEMPOROMANDIBULAR JOINT; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; CARTILAGE, ARTICULAR; CELLS, CULTURED; CHONDROCYTES; CHONDROSARCOMA; ENZYME-LINKED IMMUNOSORBENT ASSAY; INTERLEUKIN-1BETA; NF-KAPPA B; NITRILES; PROTO-ONCOGENE PROTEINS; RABBITS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SULFONES; TEMPOROMANDIBULAR JOINT; UP-REGULATION; WNT PROTEINS;

EID: 78650306625     PISSN: 10634584     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.joca.2010.10.016     Document Type: Article

References (42)

1. Hashimoto M., Nakasa T., Hikata T., Asahara H. Molecular network of cartilage homeostasis and osteoarthritis. Med Res Rev 2008, 28(3):464-481.
2. Bauge C., Attia J., Leclercq S., Pujol J.P., Galera P., Boumediene K. Interleukin-1beta up-regulation of Smad7 via NF-kappaB activation in human chondrocytes. Arthritis Rheum 2008, 58(1):221-226.
3. Fan Z., Bau B., Yang H., Aigner T. IL-1beta induction of IL-6 and LIF in normal articular human chondrocytes involves the ERK, p38 and NFkappaB signaling pathways. Cytokine 2004, 28(1):17-24.
4. Maier R., Bilbe G., Rediske J., Lotz M. Inducible nitric oxide synthase from human articular chondrocytes: cDNA cloning and analysis of mRNA expression. Biochim Biophys Acta 1994, 1208(1):145-150.
5. Li Q., Verma I.M. NF-kappaB regulation in the immune system. Nat Rev Immunol 2002, 2(10):725-734.
6. Ghosh S., Karin M. Missing pieces in the NF-kappaB puzzle. Cell 2002, 109(2):S81-S96.
7. Nusse R. Wnt signaling in disease and in development. Cell Res 2005, 15(1):28-32.
8. Chien A.J., Conrad W.H., Moon R.T. A Wnt survival guide: from flies to human disease. J Invest Dermatol 2009, 129(7):1614-1627.
9. van Amerongen R., Mikels A., Nusse R. Alternative wnt signaling is initiated by distinct receptors. Sci Signal 2008, 1(35). re9.
10. Corr M. Wnt-beta-catenin signaling in the pathogenesis of osteoarthritis. Nat Clin Pract Rheumatol 2008, 4(10):550-556.
11. Luyten F.P., Tylzanowski P., Lories R.J. Wnt signaling and osteoarthritis. Bone 2009, 44(4):522-527.
12. Lodewyckx L., Lories R.J. WNT Signaling in osteoarthritis and osteoporosis: what is the biological significance for the clinician?. Curr Rheumatol Rep 2009, 11(1):23-30.
13. Meng J., Ma X., Ma D., Xu C. Microarray analysis of differential gene expression in temporomandibular joint condylar cartilage after experimentally induced osteoarthritis. Osteoarthritis Cartilage 2005, 13(12):1115-1125.
14. Church V., Nohno T., Linker C., Marcelle C., Francis-West P. Wnt regulation of chondrocyte differentiation. J Cell Sci 2002, 115(Pt 24):4809-4818.
15. Kawakami Y., Wada N., Nishimatsu S.I., Ishikawa T., Noji S., Nohno T. Involvement of Wnt-5a in chondrogenic pattern formation in the chick limb bud. Dev Growth Differ 1999, 41(1):29-40.
16. Yang Y., Topol L., Lee H., Wu J. Wnt5a and Wnt5b exhibit distinct activities in coordinating chondrocyte proliferation and differentiation. Development 2003, 130(5):1003-1015.
17. Sen M., Chamorro M., Reifert J., Corr M., Carson D.A. Blockade of Wnt-5A/frizzled 5 signaling inhibits rheumatoid synoviocyte activation. Arthritis Rheum 2001, 44(4):772-781.
18. Sen M. Wnt signalling in rheumatoid arthritis. Rheumatology (Oxford) 2005, 44(6):708-713.
19. Nakamura Y., Nawata M., Wakitani S. Expression profiles and functional analyses of Wnt-related genes in human joint disorders. Am J Pathol 2005, 167(1):97-105.
20. Ryu J.H., Chun J.S. Opposing roles of WNT-5A and WNT-11 in interleukin-1beta regulation of type II collagen expression in articular chondrocytes. J Biol Chem 2006, 281(31):22039-22047.
21. Ge X., Ma X., Meng J., Zhang C., Ma K., Zhou C. Role of Wnt-5A in interleukin-1beta-induced matrix metalloproteinase expression in rabbit temporomandibular joint condylar chondrocytes. Arthritis Rheum 2009, 60(9):2714-2722.
22. Blumenthal A., Ehlers S., Lauber J., Buer J., Lange C., Goldmann T., et al. The Wingless homolog WNT5A and its receptor Frizzled-5 regulate inflammatory responses of human mononuclear cells induced by microbial stimulation. Blood 2006, 108(3):965-973.
23. Dissanayake S.K., Olkhanud P.B., O'Connell M.P., Carter A., French A.D., Camilli T.C., et al. Wnt5A regulates expression of tumor-associated antigens in melanoma via changes in signal transducers and activators of transcription 3 phosphorylation. Cancer Res 2008, 68(24):10205-10214.
24. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001, 25(4):402-408.
25. Huang J., Teng L., Li L., Liu T., Li L., Chen D., et al. ZNF216 Is an A20-like and IkappaB kinase gamma-interacting inhibitor of NFkappaB activation. J Biol Chem 2004, 279(16):16847-16853.
26. Gan Y., Shen Y.H., Wang J., Wang X., Utama B., Wang J., et al. Role of histone deacetylation in cell-specific expression of endothelial nitric-oxide synthase. J Biol Chem 2005, 280(16):16467-16475.
27. Zhang C.G., Jia Z.Q., Li B.H., Zhang H., Liu Y.N., Chen P., et al. Beta-Catenin/TCF/LEF1 can directly regulate phenylephrine-induced cell hypertrophy and Anf transcription in cardiomyocytes. Biochem Biophys Res Commun 2009, 390(2):258-262.
28. Zhang H., Yi X., Sun X., Yin N., Shi B., Wu H., et al. Differential gene regulation by the SRC family of coactivators. Genes Dev 2004, 18(14):1753-1765.
29. Da Forno P.D., Pringle J.H., Hutchinson P., Osborn J., Huang Q., Potter L., et al. WNT5A expression increases during melanoma progression and correlates with outcome. Clin Cancer Res 2008, 14(18):5825-5832.
30. Yamamoto H., Oue N., Sato A., Hasegawa Y., Yamamoto H., Matsubara A., et al. Wnt5a signaling is involved in the aggressiveness of prostate cancer and expression of metalloproteinase. Oncogene 2010, 29(14):2036-2046.
31. Roman-Blas J.A., Jimenez S.A. NF-kappaB as a potential therapeutic target in osteoarthritis and rheumatoid arthritis. Osteoarthritis Cartilage 2006, 14(9):839-848.
32. Seguin C.A., Bernier S.M. TNFalpha suppresses link protein and type II collagen expression in chondrocytes: role of MEK1/2 and NF-kappaB signaling pathways. J Cell Physiol 2003, 197(3):356-369.
33. Vincenti M.P., Brinckerhoff C.E. Transcriptional regulation of collagenase (MMP-1, MMP-13) genes in arthritis: integration of complex signaling pathways for the recruitment of gene-specific transcription factors. Arthritis Res 2002, 4(3):157-164.
34. Pulai J.I., Chen H., Im H.J., Kumar S., Hanning C., Hegde P.S., et al. NF-kappa B mediates the stimulation of cytokine and chemokine expression by human articular chondrocytes in response to fibronectin fragments. J Immunol 2005, 174(9):5781-5788.
35. Relic B., Bentires-Alj M., Ribbens C., Franchimont N., Guerne P.A., Benoit V., et al. TNF-alpha protects human primary articular chondrocytes from nitric oxide-induced apoptosis via nuclear factor-kappaB. Lab Invest 2002, 82(12):1661-1672.
36. Chen Y., Alman B.A. Wnt pathway, an essential role in bone regeneration. J Cell Biochem 2009, 106(3):353-362.
37. Hoeflich K.P., Luo J., Rubie E.A., Tsao M.S., Jin O., Woodgett J.R. Requirement for glycogen synthase kinase-3beta in cell survival and NF-kappaB activation. Nature 2000, 406(6791):86-90.
38. Umar S., Sarkar S., Wang Y., Singh P. Functional cross-talk between beta-catenin and NFkappaB signaling pathways in colonic crypts of mice in response to progastrin. J Biol Chem 2009, 284(33):22274-22284.
39. Cho M., Gwak J., Park S., Won J., Kim D.E., Yea S.S., et al. Diclofenac attenuates Wnt/beta-catenin signaling in colon cancer cells by activation of NF-kappaB. FEBS Lett 2005, 579(20):4213-4218.
40. Sun J., Hobert M.E., Duan Y., Rao A.S., He T.C., Chang E.B., et al. Crosstalk between NF-kappaB and beta-catenin pathways in bacterial-colonized intestinal epithelial cells. Am J Physiol Gastrointest Liver Physiol 2005, 289(1):G129-G137.
41. Carayol N., Wang C.Y. IKKalpha stabilizes cytosolic beta-catenin by inhibiting both canonical and non-canonical degradation pathways. Cell Signal 2006, 18(11):1941-1946.
42. Pereira C., Schaer D.J., Bachli E.B., Kurrer M.O., Schoedon G. Wnt5A/CaMKII signaling contributes to the inflammatory response of macrophages and is a target for the antiinflammatory action of activated protein C and interleukin-10. Arterioscler Thromb Vasc Biol 2008, 28(3):504-510.